Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.

Taking together, the SCF plasma level can serve as a novel diagnostic blood-circulating biomarker for patients with GBM. However, its plasma level is not correlated with GBM patients' tumor volume, PFS, or OS.